Skip to main content

Montanova Capital, LLC's Form 4 filing

Veradermics, Inc (MANE) · filed Feb 9, 2026

Accession no.
0000899140-26-000140
Filed
Feb 9, 2026, 6:28 PM ET
Trade date
Feb 4-6, 2026
Filing delay
5 daysLate
Rule 10b5-1 plan
Not checked

This filing lists 19 non-derivative transactions and 0 derivative transactions. Open-market purchases total $10.5M. It was filed 5 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Montanova Capital, LLCCIK 0001569064Director, 10% Owner
Averill Master Fund, Ltd.CIK 0001939329Director, 10% Owner
Averill Madison Master Fund, Ltd.CIK 0002021243Director, 10% Owner
Cowen AaronCIK 000186964010% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Feb 4, 2026Common stock, par value $0.00001 per sharePPurchaseAcquired+10,004$34.25+$342,6373,525,462Indirect
Feb 4, 2026Common stock, par value $0.00001 per sharePPurchaseAcquired+10,676$34.74+$370,884.243,536,138Indirect
Feb 4, 2026Common stock, par value $0.00001 per sharePPurchaseAcquired+14,659$36.27+$531,681.933,550,797Indirect
Feb 4, 2026Common stock, par value $0.00001 per sharePPurchaseAcquired+53,344$37.11+$1,979,595.843,604,141Indirect
Feb 4, 2026Common stock, par value $0.00001 per sharePPurchaseAcquired+25,908$38.09+$986,835.723,630,049Indirect
Feb 4, 2026Common stock, par value $0.00001 per sharePPurchaseAcquired+18,489$38.90+$719,222.13,648,538Indirect
Feb 4, 2026Common stock, par value $0.00001 per sharePPurchaseAcquired+1,720$34.25+$58,910372,579Indirect
Feb 4, 2026Common stock, par value $0.00001 per sharePPurchaseAcquired+1,835$34.74+$63,747.9374,414Indirect
Feb 4, 2026Common stock, par value $0.00001 per sharePPurchaseAcquired+2,519$36.27+$91,364.13376,933Indirect
Feb 4, 2026Common stock, par value $0.00001 per sharePPurchaseAcquired+9,168$37.11+$340,224.48386,101Indirect
Feb 4, 2026Common stock, par value $0.00001 per sharePPurchaseAcquired+4,453$38.09+$169,614.77390,554Indirect
Feb 4, 2026Common stock, par value $0.00001 per sharePPurchaseAcquired+3,178$38.90+$123,624.2393,732Indirect
Feb 5, 2026Common stock, par value $0.00001 per sharePPurchaseAcquired+3,832$36.07+$138,220.24397,564Indirect
Feb 5, 2026Common stock, par value $0.00001 per sharePPurchaseAcquired+19,199$36.93+$709,019.07416,763Indirect
Feb 5, 2026Common stock, par value $0.00001 per sharePPurchaseAcquired+38,771$37.63+$1,458,952.73455,534Indirect
Feb 5, 2026Common stock, par value $0.00001 per sharePPurchaseAcquired+17,835$38.67+$689,679.45473,369Indirect
Feb 5, 2026Common stock, par value $0.00001 per sharePPurchaseAcquired+16,563$39.80+$659,207.4489,932Indirect
Feb 6, 2026Common stock, par value $0.00001 per sharePPurchaseAcquired+11,183$35.97+$402,252.51501,115Indirect
Feb 6, 2026Common stock, par value $0.00001 per sharePPurchaseAcquired+19,338$36.55+$706,803.9520,453Indirect

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)